Axsome Therapeutics Inc (AXSM) Stock Analysis

Axsome Therapeutics Inc (AXSM) is a publicly traded company in the HEALTHCARE sector. It trades at $222.16, carries a market capitalization of $11.85B. This page summarizes the public market data, fundamentals, and frequently asked questions for AXSM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Axsome Therapeutics Inc currently has a Neutral sentiment score of 0.09.

About Axsome Therapeutics Inc

Axsome Therapeutics, Inc. is a biopharmaceutical company based in New York City, dedicated to developing innovative therapies for central nervous system (CNS) disorders. The company is focused on addressing significant unmet medical needs within this therapeutic area, boasting a robust pipeline of candidates targeting conditions such as depression, migraine, and chronic pain. With a strong commitment to enhancing patient outcomes and a solid scientific foundation, Axsome is strategically posi...

GNG Research Analysis

GNG Research scores Axsome Therapeutics Inc (AXSM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for AXSM.

Frequently Asked Questions

Does AXSM pay dividends?

Axsome Therapeutics Inc (AXSM) does not currently pay a regular dividend.

What is AXSM's market cap?

Axsome Therapeutics Inc (AXSM) has a market capitalization of $11.85B with a current stock price of $222.16.